Document is current
Any future updates will be listed below
-
Authors
Law, Lucy
Beckman Rehnman, Jeanette
Deminger, Anna
Klingberg, Eva
Jacobsson, Lennart T. H.
Forsblad-d’Elia, Helena http://orcid.org/0000-0001-7871-5303
-
Funding
Funding for this research was provided by:
the Health and Medical Care Executive Board of the Västra Götaland
Västerbotten’s Association Against Rheumatism
The Swedish Research Council
The Swedish Association Against Rheumatism
The Swedish Society of Medicine
The Göteborg Medical Society
the Region Västra Götaland
An unrestricted grant from Novartis
the County of Västerbotten (agreement concerning research and education of doctors).
- License Information
-
More Information
Article History
Received: 30 April 2018
Accepted: 3 December 2018
First Online: 27 December 2018
Ethics approval and consent to participate
: The study was approved by the regional ethics committee in Gothenburg, Sweden (reference number Dnr 597-08) and was performed in accordance with the Helsinki declaration. All participants gave their written informed consent.
: Not applicable.
: LTHJ has received Advisory Board Fees from Novartis, Celgene and MSD, outside the submitted work. HFd’E has received Advisory Board Fees from Sandoz, Novartis and Abbvie outside the submitted work and an unrestricted grant from Novartis. LL, JRB, AD and EK report no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
